Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2583-2589

  Sharma, Kiran Lata ^a   Yadav, Anu ^a   Gupta, Annapurna ^a   Tulsayan, Sonam ^a   Kumar, Vijay ^b   Misra, Sanjeev ^b   Kumar, Ashok ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cancer stem cells (CSC); CD44; Gallbladder cancer (GBC); Genetic susceptibility

Indexed keywords

HERMES ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CD44 GENE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GALLSTONE; GENDER; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ADULT; ANTIGENS, CD44; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GALLBLADDER NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84899070945     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1340-8     Document Type: Article

References (31)

1. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-76.
2. Roa I, Araya JC, Villaseca M, De Aretxabala X, Riedemann P, Endoh K, et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology. 1996;111:232-6.
3. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695-706.
4. Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50:2226-34.
5. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-64.
6. Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67-79.
7. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675-99.
8. Baumann M, Krause M. Cd44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 2010;16:5091-3.
9. Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, et al. Cd44+ cd133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther. 2010;10:1182-90.
10. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, et al. A novel gemini vitamin d analog represses the expression of a stem cell marker cd44 in breast cancer. Mol Pharmacol. 2011;79:360-7.
11. Bourguignon LY. Cd44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287-97.
12. Bourguignon LY, Singleton PA, Zhu H, Diedrich F. Hyaluronan-mediated cd44 interaction with rhogef and rho kinase promotes grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem. 2003;278:29420-34.
13. Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, Muller TH, et al. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and cd44 that affect sarcoma incidence and survival. Cancer Res. 2010;70:172-80.
14. Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, et al. Germline polymorphisms in genes involved in the cd44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer. 2011;129:1096-104.
15. Hiraga T, Ito S, Nakamura H. Cancer stem-like cell marker cd44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 2013;73:4112-22.
16. Kalekou H, Miliaras D. Immunohistochemical study of microvessel density, cd44 (standard form), p53 protein and c-erbb2 in gallbladder carcinoma. J Gastroenterol Hepatol. 2004;19:812-8.
17. De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ. Cd44 and cd44v6 downregulation in clinical prostatic carcinoma: relation to gleason grade and cytoarchitecture. Prostate. 1998;34:162-8.
18. Roa I, Villaseca M, Araya J, Roa J, de Aretxabala X, Ibacache G. Garcia M: [cd44 (hcam) expression in subserous gallbladder carcinoma]. Rev Med Chil. 2001;129:727-34.
19. Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, et al. Cd44 rs13347 c>t polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res. 2012;14:R105.
20. Xiao M, Hu S, Zhang L, Huang J, Jiang H, Cai X. Polymorphisms of cd44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population. Mutagenesis. 2013;28(5):577-82.
21. Sharma KL, Misra S, Kumar A, Mittal B. Higher risk of matrix metalloproteinase (mmp-2, 7, 9) and tissue inhibitor of metalloproteinase (timp-2) genetic variants to gallbladder cancer. Liver Int. 2012;32:1278-86.
22. Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 2012;7:e40162.
23. Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013; In press.
24. Lee PH, Shatkay H. F-snp: computationally predicted functional snps for disease association studies. Nucleic Acids Res. 2008;36:D820-4.
25. Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, et al. Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res. 2011;17:6934-43.
26. de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, et al. Cd44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 2010;16:5329-38.
27. Tulsyan S, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B. Cd44 gene polymorphisms in breast cancer risk and prognosis: a study in north indian population. PLOS ONE. 2013;8:e71073.
28. Yanagisawa N, Mikami T, Mitomi H, Saegusa M, Koike M, Okayasu I. Cd44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Cancer. 2001;91:408-16.
29. Yin BB, Wu SJ, Zong HJ, Ma BJ, Cai D. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line gbc-sd. J Zhejiang Univ Sci B. 2011;12:256-63.
30. Xing B, Kong YG, Yao Y, Lian W, Wang RZ, Ren ZY. Study on the expression levels of cxcr4, cxcl12, cd44, and cd147 and their potential correlation with invasive behaviors of pituitary adenomas. Biomed Environ Sci. 2013;26:592-8.
31. Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S, et al. Cd44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci. 2000;910:106-18. discussion 118-120.